NASDAQ

organization

Last mentioned: Mar 24, 2026

Timeline

  1. Zero-Emission Deadline

    New York target for a 100% zero-emission electricity sector.

  2. NY State Storage Target

    Deadline for New York to reach its 6 GW energy storage capacity goal.

  3. Project Milestones

    Anticipated advancement of detailed engineering and technical work at Elk Creek site.

  4. Spring Mobilization Phase

    Expected peak construction window for battery energy storage systems.

  5. Q4 Earnings Preview

    Seeking Alpha and other analysts release previews for the critical Q4 2025 financial results.

  6. Earnings Release

    Cheetah Net reports Q4 and Full Year 2025 results, missing EPS and revenue targets.

  7. Corporate Update

    Management provides a strategic outlook for the 2026 fiscal year focusing on supply chain resilience.

  8. Q4 2025 Earnings Call

    Management discussed clinical progress of Lomecel-B and financial outlook.

  9. Financial Reporting

    Lifeward scheduled to report Q4 and full-year 2025 financial results.

  10. Project Advancement Announced

    PowerBank confirms 42 MW across 9 projects have moved forward in NY State.

  11. Effective Date

    Shares begin trading on NASDAQ at the adjusted 1-for-25 price.

  12. Final Trading Day

    Last day of trading for MASK shares on a pre-split basis.

  13. Shareholder Approval

    Lifeward shareholders vote in favor of the strategic partnership with Oramed.

  14. Capital Raise

    Entry into a material definitive agreement for the sale of unregistered equity securities.

  15. Market Gap Down

    KDK shares open significantly lower as investors react to weak earnings and guidance.

  16. Analyst Revisions

    Several brokerage firms adjust price targets citing concerns over cash burn and commercialization timelines.

  17. Split Announcement

    Company officially announces a 25-for-1 share consolidation plan.

  18. Nasdaq Compliance

    Lifeward regains compliance with Nasdaq minimum bid price requirements.

  19. Earnings Release

    Kodiak AI files Form 8-K detailing Q4 financial results and operational performance.

  20. NASDAQ Compliance Notice

    Longeveron received notice of failure to satisfy NASDAQ listing rules.

Stories mentioning NASDAQ 20

pharma Neutral

Longeveron Navigates Capital Constraints Amid Lomecel-B Clinical Progress

Longeveron Inc. (LGVN) reported Q4 2025 results, highlighting clinical advancements in its Lomecel-B cell therapy for rare pediatric heart conditions and Alzheimer's disease. Despite clinical momentum, the company is managing significant financial headwinds, including a recent NASDAQ compliance notice and a subsequent capital raise in March 2026.

4 sources
ipo Neutral

BHAV Acquisition Prices $100M IPO, Signaling a Shift in SPAC Deal Structures

BHAV Acquisition Corp. has priced its $100 million initial public offering at $10 per unit, listing on the Nasdaq to target mid-market acquisition opportunities. The offering utilizes a rights-based structure designed to minimize dilution, reflecting a more disciplined approach to the blank-check model.

2 sources
market-trends Neutral

Hologic Short Interest Surges 71.7% as Market Sentiment Shifts Bearish

Hologic, Inc. (NASDAQ: HOLX) has experienced a dramatic 71.7% increase in short interest, signaling a significant shift in investor sentiment toward the medical technology leader. This surge suggests growing skepticism regarding the company's near-term growth prospects in its core women's health and diagnostics segments.

2 sources
earnings Neutral

Kodiak AI Shares Plunge as Q4 Earnings Miss Sparks Growth Concerns

Kodiak AI (NASDAQ: KDK) experienced a significant share price gap down following the release of its Q4 financial results, which fell short of analyst expectations. The market reaction underscores growing investor impatience with high R&D burn rates in the autonomous vehicle and AI logistics sector.

2 sources
markets Neutral

MidCap Financial Investment Shares Gap Down Following Analyst Downgrade

MidCap Financial Investment (MFIC) saw its shares gap down significantly on March 10, 2026, following a targeted analyst downgrade. The market reaction underscores growing sensitivity toward credit quality and dividend sustainability within the Business Development Company (BDC) sector.

2 sources
logistics Neutral

L.B. Foster Hits 7-Year Sales Peak Amid Global Rail Infrastructure Surge

L.B. Foster Company (FSTR) reported its strongest fourth-quarter sales performance since 2018, driven by a strategic shift toward high-margin technology solutions. The company's 2025 results highlight a significant turnaround in profitability and operating cash flow, signaling a successful pivot toward digital rail and critical infrastructure markets.

2 sources
adtech Neutral

PubMatic Surpasses Q4 Earnings Estimates with Significant $0.13 EPS Beat

PubMatic (NASDAQ: PUBM) has reported quarterly earnings that significantly outperformed analyst expectations, delivering an EPS beat of $0.13. The results highlight the company's successful navigation of the programmatic advertising market through infrastructure ownership and supply-path optimization.

2 sources
earnings Neutral

OneStream and Seer Outperform Q4 Estimates Amid Enterprise Cloud Resilience

OneStream (OS) and Seer (SEER) both reported quarterly earnings that exceeded analyst expectations, signaling continued demand for high-performance data and financial management platforms. OneStream led the pair with a $0.07 EPS beat, while Seer posted a $0.03 beat, reflecting a broader trend of operational efficiency in the enterprise software and life sciences technology sectors.

2 sources
market-trends Bullish

AI Optimism Drives Global Markets to Historic Record Highs

Global equity markets surged to unprecedented levels on February 25, 2026, as investor anxiety over artificial intelligence's long-term profitability and regulatory risks began to dissipate. This rally signals a shift in market sentiment from speculative caution to a fundamental belief in AI-driven productivity gains across the enterprise sector.

3 sources
funding Neutral

NioCorp Developments Secures $100M to Advance Domestic Critical Mineral Supply

NioCorp Developments has successfully closed a $100 million public offering of common shares to accelerate the development of its Elk Creek Critical Minerals Project. The capital infusion marks a significant milestone in the company's effort to establish a domestic supply chain for niobium, scandium, and titanium.

2 sources